Biopsy Devices Market: A Comprehensive Analysis and Future Projections - 2028

-

According to the latest report the biopsy devices market is projected to reach USD 12.6 billion by 2028 from USD 6.6 billion in 2023, at a CAGR of 14.0% from 2023 to 2028. Advancements in medical technology have led to the development of more precise and minimally invasive biopsy tools, reducing patient discomfort and recovery times. Secondly, an aging global population has increased the demand for cancer screening and diagnosis, where biopsies play a crucial role. Additionally, the rising incidence of cancer and other chronic diseases has spurred the need for more frequent and accurate tissue sampling.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132886515

Opportunity: Technological Advancements

Continued innovation in biopsy device technology, such as improved imaging capabilities, robotics, and precision-guided biopsy tools, offers opportunities for more accurate and less invasive procedures. Advanced imaging techniques such as ultrasound, magnetic resonance imaging (MRI), and computed tomography (CT) scans have become integral in guiding biopsy procedures. For instance, real-time ultrasound imaging allows healthcare professionals to precisely target and extract tissue samples, minimizing the risk of complications.

Challenge: Underdeveloped healthcare infrastructure and dearth of resources in developing countries

With the growing awareness about different types of cancers, the demand for biopsy procedures in developing countries is expected to increase in the coming years. Due to limited healthcare resources and underdeveloped infrastructure, alternative strategies for diagnosis of breast cancer are widely used in the region. Mortality caused due to breast cancer is also higher in low- and middle-income countries as compared to high-income countries. This is mainly due to the lack of early detection in these countries.

The biopsy devices market is moderately competitive, with both established companies and upcoming competitors for the same market share. As of 2022, the key player operating in the global biopsy devices market are Becton, Dickinson and Company (US), Devicor Medical Products, Inc., (Leica Biosystems) (US), B. Braun Melsungen AG (Germany), Hologic, Inc. (US), and Cardinal Health, Inc. (US) among others.

The key strategies adopted by the top players in this market in the last four years include product launches & expansions, partnerships, acquisitions, and collaborations. In 2022, a major share of the Biopsy devices market was held by Becton, Dickinson and Company (US), Devicor Medical Products, Inc., (Leica Biosystems) (US), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (US)

Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=132886515

The Asia Pacific market to register a significant growth in the market during the forecast period

The Asia Pacific biopsy devices market is estimated to register a significant growth from 2023 to 2028. The increasing patient population, rising geriatric population, rapid economic growth and increasing disposable income are driving the market growth in APAC countries. This region is having a rise in healthcare investment and expenditure, offering significant growth opportunities for the key players.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Comments

Post a Comment

Popular posts from this blog

Future of Remote Patient Monitoring Industry: Impact of Remote Patient Monitoring on Healthcare

-
Remote patient monitoring is a type of telemedicine technology that enables healthcare providers to monitor their patients’ health remotely. This technology utilizes remote devices that are placed in the patient’s home or worn by the patient to collect medical data such as vital signs and other medical information.  This medical data is then transmitted to the doctor or healthcare provider to help them make better decisions regarding the patient’s care. RPM can be used to monitor a variety of conditions including chronic diseases, mental health issues, and post-operative care. It can also be used to support elderly individuals and those with disabilities. RPM has the potential to improve patient outcomes and reduce healthcare costs by enabling healthcare providers to monitor their patients’ health more effectively. Benefits of Remote Patient Monitoring 1. Increased Patient Engagement: Remote patient monitoring systems provide patients with a convenient way to stay engaged in their ow
Read more

Sinus Dilation Devices Market Size And Share Report, 2027

-
The sinus dilation devices market is on track for significant growth in the coming years, projected to reach USD 3.8 billion by 2027, up from USD 2.8 billion in 2022. This represents a compound annual growth rate (CAGR) of 6.6% during the forecast period. The market's expansion is largely driven by the increasing availability of reimbursements and rising cases of chronic sinusitis. However, the market faces challenges due to the availability of non-surgical treatments for chronic sinusitis and a shortage of skilled ENT surgeons. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810 Key Market Drivers Increasing Availability of Reimbursements: The growing availability of reimbursements for sinus dilation procedures is making them more accessible to patients, thereby driving demand for sinus dilation devices. Rising Incidence of Chronic Sinusitis: The prevalence of chronic sinusitis is on the rise globally, leading to an increase in d
Read more

Stable Isotope Labeled Compounds Market Growth: Trends and Opportunities

-
The global stable isotope labeled compounds market size is projected to reach USD 312 million by 2024 from USD 269 million in 2019, at a CAGR of 3.0% between 2019 and 2024. The growth of this market is driven majorly by the increase in research activities in the pharmaceutical and biotechnology sector, the rising prevalence of cancer, and rising proteomics research. However, the high cost of stable isotope-labeled compounds is expected to restrain the growth of this market during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=53034199 The H-2 labeled compounds segment accounted for the largest share of the stable isotope labeled compounds market. Based on type, the stable isotope labeled compounds industry is segmented into C-13, N-15, O-18, H-2 (deuterium), and other isotopes. The H-2 labeled compounds segment accounted for the largest share of the stable isotope-labeled compounds market in 2019. The large share of this
Read more